INDICATIONS OF COAGULOGRAM IN POST-COVID SYNDROME
Abstract
Сoronavirus infection (COVID-19) is an acute infectious disease caused by the SARS-CoV-2 virus, which is manifested by the activation of the hemostasis system, which in severe cases can lead to the development of coagulopathy. Currently, it is not fully determined whether COVID-19 is the direct cause of these disorders or whether it exacerbates the infectious process. Asymptomatic development of COVID-19 and the development of clinically obvious thrombotic or thromboembolic complications remain unclear, which is mainly due to the difficulties in their diagnosis. Therefore, in the development of severe clinical forms of COVID-19, it is important to study the features of activation of the blood clotting system and, accordingly, to detect this disease early. Often, various clinical,COVID-19enough to solve a specific diagnostic and therapeutic problem during the treatment of patients with
References
Long-covid. Chto eto takoye i kak ego lechit. RBK Life. Data processing: February 16, 2023.
Goldobin VV Atherothrombotic stroke: clinical indicators and parameters of thrombocytic hemostasis in patients in the acute period // Saratovskii nauchno-medisinskii zurnal.—2012.—T.8.—№4.—S.954–957.
Boltayeva, FG; «Clinical-laboratory manifestation of COVID-19» 2022. Current problems of modern clinical laboratory diagnosis.
Suleymanova D.N., Rakhmanova U.U., Davlatova G.N.; Evaluation of the effectiveness of chelation therapy and the role of the cellular link of immunity in beta-thalassemia.”Journal of Theoretical and Clinical Medicine", p.137, No. 5, 2021
Rakhmanova, UU; Suleymanova, DN; Shamsutdinova, MI; Masharipova, I Yu; Ishchanova, NH; The study of the relationship of indicators of immune status and serum ferritin in patients with thalassemia, International Journal of Psychosocial Rehabilitation, 24. 9. 423-426, 2020
Rakhmanova U.U; Yusupova, IA; Bobojonova Sh, D; Rustamova, NX; Diagnostic and predictive significance of immunological disorders in β-Thalassemia, 2021. American Journal of Medicine and Medical Sciences.
Rakhmanova U.U.; Aspects of clinical and laboratory data of liver diseases in hemolytic anemia, Issues of science and education,,23 (35),130-132,2018, Olymp LLC
Rakhmanova U.U.; Satlikov R.K.; "Features of immunological markers in patients with beta-thalassemia, zamonaviy clinic laboratory tashhisi dolzarb muammolari".,1.160-161., 2022.Dr. Zotova IV. Osenka risk of thromboembolism in cardiac arrhythmia: current state problems // Atherothrombosis.—2013—№1—S.21–32.
Rakhmanova U.U. Study of the detectability and assessment of the quality of life of patients with thalassemia before and after chelation therapy. ”Journal of Theoretical and Clinical Medicine" , p.142, No. 5, 2021
Mirkhamidovna Sharifa Fazilova, Soburovna Dilfuza Matkarimova; «The range of functional mutations and their contribution to the formation of blast cells and the development of leukemia (Literature review)»,"Finland International Scientific Journal of Education, Social Science & Humanities". 116.450-458.2023.
Fazilova Sh. M; Karimov Kh. Ya.; "The efficiency of the application of the new preparation" reomannisol" in hemolytic anemia in experiment". Eurasia Science. 43-44. 2018.
Bennett J, Dolin R, Blaser MJ. Principles and Practice of Infectious Diseases. 8thEdition//Elsevier.-2014.-№8 (2)-p.3904.
Bhimraj A, Morgan RL, Shumaker AH et al. Infectious Diseases Society of America Guidelines on the Treatment and Management of Patients with COVID-19. ClinInfectDis. 2020:ciaa478.doi:10.1093/cid/ciaa478.
Chan et al. Simulation of the clinical and pathological manifestations of the Coronavirus Disease 2019 (COVID-19) in the golden Syrian hamster model: implications for disease pathogenesis and transmissibility. //Clin. Infect. Dis. –2020.–№3;71(9).–R.2428-2446.doi:10.1093/cid/ciaa325.
Deng Y., Zou JH, Sun SS, Liu BJ, Wang L., Shi JY, Xiong XA and Zhang SF Tag-based Analysis at the BESIII Experiment. Journal of Physics: Conference Series 1525 (2020) V 314. 012083 IOP Publishing doi:10.1088/1742-6596/1525/1/012083.
Fazilova Sharifa Mirkhamidovna; «Clinical and laboratory aspects in multiple myeloma (Literature review)». O'zbekistonda fanlararo innovatsiyalar va ilmiy tadqiqotlar jurnali 220.203-206.2023.
Huang C, Wang Y, Li X et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. // Lancet.-2020.-№ 395(10223).-p.497–506.
Babadzhanova, SHA; Matkarimova, DS; Boltayeva, FG; Osyenka disordered systemic hemostasis and patients with COVID-19, 2021, Theoretical and clinical medicine.
Boltayeva, FG; Rakhmanova, UU; Babadzhanova, SHA; , Izucheniye klinicheskogo techenia i hemostasiologicheskikh narusheniy u bolnykh koronavirusom v period voyvoy volny COVID-19 v Khorezmskoy oblasti, 2022, Tashkent
